|
Matching placebo Clinical Trials
9 actively recruiting trials across 7 locations
No change since May 2026
Also known as: Placebo, placebo
Pipeline
Phase 1: 2Phase 2: 5Phase 3: 2
Top Sponsors
- University of Colorado, Denver2
- Novartis Pharmaceuticals2
- Yale University1
- Rajesh Kumar1
- Hua Medicine Limited1
Other2 trials
Huntsville, Alabama1 trial
Springdale, Arkansas1 trial
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Highlands Oncology Group
Phase 3
Aurora, Colorado1 trial
Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
University of Colorado Anschutz Medical Campus
Phase 2
New Haven, Connecticut1 trial
Empagliflozin in Patients With Cirrhosis and Ascites
Yale University
Phase 2
Miami, Florida1 trial
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
Clinical Pharmacology of Miami
Phase 1
Chicago, Illinois1 trial
Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Ann and Robert H Lurie Childrens Hospital of Chicago
Phase 2
Durham, North Carolina1 trial
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
Duke University (Asthma, Allergy and Airway Center)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.